Contact
Please use this form to send email to PR contact of this press release:
First Participants Enrolled in the AriBio USA Phase 3 Registration Trial to Evaluate AR1001 in Early Alzheimer's Disease
TO:
Please use this form to send email to PR contact of this press release:
First Participants Enrolled in the AriBio USA Phase 3 Registration Trial to Evaluate AR1001 in Early Alzheimer's Disease
TO: